Press "Enter" to skip to content

Gilead Nears Deal To Buy Immunomedics For More Than $20 Billion, WSJ Reports

UK-IMMUNOMEDICS-M-A-GILEAD-SCIENCES:Gilead nears deal to purchase Immunomedics for greater than $20 billion, WSJ stories

Gilead Sciences Inc is nearing a deal to purchase biopharmaceutical firm Immunomedics Inc for greater than $20 billion, the Wall Street Journal reported on Saturday, citing individuals accustomed to the matter.

  • Reuters
  • Last Updated: September 13, 2020, 2:06 AM IST

  • FOLLOW US ON:

Gilead Sciences Inc is nearing a deal to purchase biopharmaceutical firm Immunomedics Inc for greater than $20 billion, the Wall Street Journal reported on Saturday, citing individuals accustomed to the matter.

A deal for Immunomedics, which final month reported constructive information from a late-stage examine for its breast-cancer drug, could possibly be introduced Monday if not sooner, the Journal mentioned https://www.wsj.com/articles/gilead-nears-deal-to-buy-immunomedics-for-more-than-20-billion-11599936777?mod=hp_lead_pos2.






Gilead and Immunomedics didn’t reply instantly to emailed requests from Reuters for remark.

Disclaimer: This submit has been auto-published from an company feed with none modifications to the textual content and has not been reviewed by an editor


Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    %d bloggers like this: